122 related articles for article (PubMed ID: 8400458)
1. Selective protein degradation in the yeast exocytic pathway.
McCracken AA; Kruse KB
Mol Biol Cell; 1993 Jul; 4(7):729-36. PubMed ID: 8400458
[TBL] [Abstract][Full Text] [Related]
2. Yeast mutants deficient in ER-associated degradation of the Z variant of alpha-1-protease inhibitor.
McCracken AA; Karpichev IV; Ernaga JE; Werner ED; Dillin AG; Courchesne WE
Genetics; 1996 Dec; 144(4):1355-62. PubMed ID: 8978025
[TBL] [Abstract][Full Text] [Related]
3. ADD66, a gene involved in the endoplasmic reticulum-associated degradation of alpha-1-antitrypsin-Z in yeast, facilitates proteasome activity and assembly.
Scott CM; Kruse KB; Schmidt BZ; Perlmutter DH; McCracken AA; Brodsky JL
Mol Biol Cell; 2007 Oct; 18(10):3776-87. PubMed ID: 17634286
[TBL] [Abstract][Full Text] [Related]
4. Construction and expression of alpha 1-proteinase inhibitor mutants and the effects of these mutations on secretion of the variant inhibitors.
McCracken AA; Kruse KB; Valentine J; Roberts C; Yohannes TZ; Brown JL
J Biol Chem; 1991 Apr; 266(12):7578-82. PubMed ID: 2019587
[TBL] [Abstract][Full Text] [Related]
5. Characterization of an ERAD gene as VPS30/ATG6 reveals two alternative and functionally distinct protein quality control pathways: one for soluble Z variant of human alpha-1 proteinase inhibitor (A1PiZ) and another for aggregates of A1PiZ.
Kruse KB; Brodsky JL; McCracken AA
Mol Biol Cell; 2006 Jan; 17(1):203-12. PubMed ID: 16267277
[TBL] [Abstract][Full Text] [Related]
6. Tipping the delicate balance: defining how proteasome maturation affects the degradation of a substrate for autophagy and endoplasmic reticulum associated degradation (ERAD).
Brodsky JL; Scott CM
Autophagy; 2007; 3(6):623-5. PubMed ID: 17786020
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis for defective secretion of the Z variant of human alpha-1-proteinase inhibitor: secretion of variants having altered potential for salt bridge formation between amino acids 290 and 342.
McCracken AA; Kruse KB; Brown JL
Mol Cell Biol; 1989 Apr; 9(4):1406-14. PubMed ID: 2786139
[TBL] [Abstract][Full Text] [Related]
8. Differential requirements of novel A1PiZ degradation deficient (ADD) genes in ER-associated protein degradation.
Palmer EA; Kruse KB; Fewell SW; Buchanan SM; Brodsky JL; McCracken AA
J Cell Sci; 2003 Jun; 116(Pt 11):2361-73. PubMed ID: 12711700
[TBL] [Abstract][Full Text] [Related]
9. Degradation of Rhizopus niveus aspartic proteinase-I with mutated prosequences occurs in the endoplasmic reticulum of Saccharomyces cerevisiae.
Fukuda R; Umebayashi K; Horiuchi H; Ohta A; Takagi M
J Biol Chem; 1996 Jun; 271(24):14252-5. PubMed ID: 8662920
[TBL] [Abstract][Full Text] [Related]
10. Production and characterization of a novel human recombinant alpha-1-antitrypsin in PER.C6 cells.
Ross D; Brown T; Harper R; Pamarthi M; Nixon J; Bromirski J; Li CM; Ghali R; Xie H; Medvedeff G; Li H; Scuderi P; Arora V; Hunt J; Barnett T
J Biotechnol; 2012 Dec; 162(2-3):262-73. PubMed ID: 23036927
[TBL] [Abstract][Full Text] [Related]
11. Expression and degradation of the cystic fibrosis transmembrane conductance regulator in Saccharomyces cerevisiae.
Kiser GL; Gentzsch M; Kloser AK; Balzi E; Wolf DH; Goffeau A; Riordan JR
Arch Biochem Biophys; 2001 Jun; 390(2):195-205. PubMed ID: 11396922
[TBL] [Abstract][Full Text] [Related]
12. Intracellular trafficking and metabolic turnover of yeast prepro-alpha-factor-SRIF precursors in GH3 cells.
Lee MA; Cheong KH; Shields D; Park SD; Hong SH
Exp Mol Med; 2002 Sep; 34(4):285-93. PubMed ID: 12515394
[TBL] [Abstract][Full Text] [Related]
13. Glycosylation and secretion of human alpha-1-antitrypsin by yeast.
Moir DT; Dumais DR
Gene; 1987; 56(2-3):209-17. PubMed ID: 3315863
[TBL] [Abstract][Full Text] [Related]
14. A study of the effects of altering the sites for N-glycosylation in alpha-1-proteinase inhibitor variants M and S.
Samandari T; Brown JL
Protein Sci; 1993 Sep; 2(9):1400-10. PubMed ID: 8401226
[TBL] [Abstract][Full Text] [Related]
15. Sec3p is needed for the spatial regulation of secretion and for the inheritance of the cortical endoplasmic reticulum.
Wiederkehr A; Du Y; Pypaert M; Ferro-Novick S; Novick P
Mol Biol Cell; 2003 Dec; 14(12):4770-82. PubMed ID: 12960429
[TBL] [Abstract][Full Text] [Related]
16. Structural characterization of recombinant alpha-1-antitrypsin expressed in a human cell line.
Wang Z; Hilder TL; van der Drift K; Sloan J; Wee K
Anal Biochem; 2013 Jun; 437(1):20-8. PubMed ID: 23462539
[TBL] [Abstract][Full Text] [Related]
17. Quality control of protein C: protein C synthesized in the presence of warfarin is selectively degraded in the endoplasmic reticulum.
Koide T; Tokunaga F; Wakabayashi S
Pol J Pharmacol; 1996; 48(2):203-7. PubMed ID: 9112652
[TBL] [Abstract][Full Text] [Related]
18. Effects of mutations that alter the Glu264-Lys387 salt bridge on the secretion of alpha-1-proteinase inhibitor.
Brodbeck RM; Samandari T; Brown JL
J Biol Chem; 1993 Mar; 268(9):6771-6. PubMed ID: 8454649
[TBL] [Abstract][Full Text] [Related]
19. Intracellular degradation of the transport-impaired human PiZ alpha 1-antitrypsin variant. Biochemical mapping of the degradative event among compartments of the secretory pathway.
Le A; Graham KS; Sifers RN
J Biol Chem; 1990 Aug; 265(23):14001-7. PubMed ID: 2380201
[TBL] [Abstract][Full Text] [Related]
20. Transport of newly synthesized sterol to the sterol-enriched plasma membrane occurs via nonvesicular equilibration.
Baumann NA; Sullivan DP; Ohvo-Rekilä H; Simonot C; Pottekat A; Klaassen Z; Beh CT; Menon AK
Biochemistry; 2005 Apr; 44(15):5816-26. PubMed ID: 15823040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
